查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1525927

婴儿临床营养市场：全球产业分析、规模、份额、成长、趋势、预测，2024-2033 年

Infant Clinical Nutrition Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 159 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球婴儿临床营养市场的综合报告。该报告全面评估了主要市场动态，包括市场驱动因素、趋势、机会和课题，并提供了有关市场结构的详细见解。

重要见解

  • 婴儿临床营养市场规模（2024年）：274.918亿美元
  • 市场预测值（2033F）：457.337亿美元
  • 全球市场成长率（2024年至2033年复合年增长率）：5.8%

婴儿临床营养市场 - 报告范围：

婴儿临床营养在全球支持新生儿和婴儿的健康和发育方面发挥着重要作用。该市场包括专为婴儿设计的各种营养产品，例如婴儿配方奶粉、婴儿食品和营养补充剂。该市场的主要利益相关者包括製造商、医疗保健提供者和监管机构，每个人都为市场成长和监管框架做出了贡献。

市场成长动力：

全球婴儿临床营养市场由几个关键因素推动，包括出生率的提高、对幼儿营养重要性的认识不断提高以及营养科学的进步。市场扩张是由对专门婴儿配方奶粉的需求推动的，这些配方奶粉可以解决各种健康问题，包括乳糖不耐症、过敏和早产併发症。此外，注重健康的父母越来越多地采用有机和天然婴儿食品，这进一步推动了市场的成长。

市场限制因素：

儘管成长前景广阔，但婴儿临床营养市场面临严格监管要求的课题，特别是在产品安全、标籤和声明方面。此外，经济波动、定价压力和供应链中断正在影响市场动态，并对旨在实现永续获利和市场扩张的市场参与者构成课题。

市场机会：

由于人口趋势、不断变化的饮食偏好以及营养研究的进步，婴儿临床营养市场呈现出巨大的成长机会。产品配方的创新，例如低过敏性婴儿配方奶粉和富含益生菌的婴儿食品，正在满足消费者对更健康、更功能性婴儿营养选择的新需求。製造商、医疗保健提供者和营养学家之间的策略合作对于开发基于证据的营养解决方案和向不同人群拓展市场至关重要。

本报告解决的关键问题

  • 推动全球婴儿临床营养市场成长的关键因素是什么？
  • 哪些产品领域和营养配方越来越受到家长和医疗保健提供者的采用？
  • 监管环境与消费者偏好如何形塑婴儿临床营养市场的竞争格局？
  • 谁是对婴儿临床营养市场做出贡献的主要公司？ 他们保持市场领先地位的策略是什么？
  • 全球婴幼儿临床营养市场有何新趋势与未来前景？

目录

第1章 内容提要

第2章 市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 主要市场趋势

  • 影响市场的主要趋势
    • 出生率上升和早产增加增加了对婴儿营养补充剂的需求
    • 婴儿食品营养改善的进步推动市场成长
  • 产品创新/发展趋势

第4章 关键成功因素

  • 产品采用/使用分析
  • 产品 USP/特点
  • 战略推广策略

第五章全球婴儿临床营养市场-价格分析

  • 2019-2023年区域价格趋势分析
  • 全球平均价格分析基准

第六章全球婴幼儿临床营养市场需求（价值百万美元）分析

  • 2019-2023 年历史市值（百万美元）分析
  • 2024-2033 年当前和未来市场价值（百万美元）预测
    • 同比增长趋势分析
    • 绝对的获利机会

第7章 市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 全球食品饮料行业概览
  • 全球乳製品产业概况
  • 供应炼和价值链分析
  • 政策制定和监管情势
  • 市场动态
  • 全球供需分析

第八章全球婴儿临床营养市场分析：产品类型

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）（按产品类型）
  • 2024-2033 年当前和未来市场规模（百万美元）以及按产品类型分析和预测
    • 乳基
    • 以大豆为基础
    • 有机的
    • 益生菌/益生元
  • 按产品类型分析市场吸引力

第九章全球婴儿临床营养市场分析：依给药途径

  • 简介/主要发现
  • 2019-2023 年市场规模（百万美元）和数量分析（按管理方式）
  • 目前和未来的市场规模（百万美元）以及定量分析和预测（按管理方式，2024-2033 年）
    • 口服给药
    • 肠内给药
    • 静脉给药
  • 依给药途径进行市场吸引力分析

第十章全球婴儿临床营养市场分析：按地区

  • 介绍
  • 2019-2023 年按地区划分的市场规模（百万美元）和销售分析
  • 2024-2033 年按地区划分的当前市场规模（百万美元）和销售分析与预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 南亚和太平洋地区
    • 东亚
    • 中东和非洲
  • 按地区划分的市场吸引力分析

第十一章北美婴儿临床营养市场分析

第十二章拉丁美洲婴儿临床营养市场分析

第十三章欧洲婴儿临床营养市场分析

第14章南亚及太平洋地区婴儿临床营养市场分析

第十五章东亚婴幼儿临床营养市场分析

第十六章中东与非洲婴幼儿临床营养市场分析

第十七章 2024 年各国婴儿临床营养市场分析

  • 介绍
  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷
  • 德国
  • 义大利
  • 法国
  • 英国
  • 西班牙
  • 波兰
  • 俄罗斯
  • 中国
  • 日本
  • 韩国
  • 印度
  • 大洋洲（澳洲、纽西兰）
  • 土耳其
  • 南非

第18章 市场结构分析

  • 按公司类别划分的市场分析（婴儿临床营养）
  • 主要参与者的市场份额分析
  • 市场存在分析

第19章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 衝突详情
    • Abbott Laboratories
    • Baxter International
    • Nestle SA
    • Danone
    • Meiji Holdings Co., Ltd.
    • Fresenius SE & Co. KGaA
    • Reckitt Benckiser Group Plc
    • Perrigo Co. Plc
    • Ingredion Inc.
    • Solace Nutrition
    • 其他（根据额外要求）

第20章 所使用的假设与缩写词

第21章 研究方法论

简介目录
Product Code: PMRREP22363

Persistence Market Research has recently released a comprehensive report on the worldwide market for infant clinical nutrition. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Infant Clinical Nutrition Market Size (2024E): USD 27491.8 Mn
  • Projected Market Value (2033F): USD 45733.7 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.8%

Infant Clinical Nutrition Market - Report Scope:

Infant clinical nutrition plays a critical role in supporting the health and development of newborns and infants globally. This market encompasses a wide range of nutritional products designed specifically for infants, including infant formula, baby food, and nutritional supplements. Key stakeholders in this market include manufacturers, healthcare providers, and regulatory bodies, each contributing to the market's growth and regulatory framework.

Market Growth Drivers:

The global infant clinical nutrition market is driven by several key factors, including increasing birth rates, rising awareness about the importance of early childhood nutrition, and advancements in nutritional science. The demand for specialized infant formulas catering to various health conditions such as lactose intolerance, allergies, and preterm birth complications fuels market expansion. Moreover, the growing adoption of organic and natural infant food products among health-conscious parents further stimulates market growth.

Market Restraints:

Despite promising growth prospects, the infant clinical nutrition market faces challenges related to stringent regulatory requirements, particularly concerning product safety, labeling, and advertising claims. Additionally, economic fluctuations, pricing pressures, and supply chain disruptions impact market dynamics, posing challenges for market players aiming for sustained profitability and market expansion.

Market Opportunities:

The infant clinical nutrition market presents significant growth opportunities driven by demographic trends, evolving dietary preferences, and advancements in nutritional research. Innovations in product formulations, such as hypoallergenic formulas and probiotic-enriched baby foods, cater to emerging consumer demands for healthier and functional infant nutrition options. Strategic collaborations between manufacturers, healthcare providers, and nutritionists are crucial in developing evidence-based nutritional solutions and expanding market reach across diverse demographic segments.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the infant clinical nutrition market globally?
  • Which product segments and nutritional formulations are witnessing increased adoption among parents and healthcare providers?
  • How are regulatory developments and consumer preferences shaping the competitive landscape of the infant clinical nutrition market?
  • Who are the key players contributing to the infant clinical nutrition market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global infant clinical nutrition market?

Competitive Intelligence and Business Strategy:

Leading players in the global infant clinical nutrition market, including Nestle S.A., Abbott Laboratories, Danone S.A., Mead Johnson Nutrition Company, and Reckitt Benckiser Group plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce new nutritional products tailored to specific health needs and consumer preferences. Collaborations with pediatricians, hospitals, and retail channels enhance product distribution and market penetration, ensuring comprehensive infant nutrition solutions globally.

Key Companies Profiled:

  • Abbott Laboratories
  • Baxter International Inc.
  • Nestle S.A.
  • Danone
  • Meiji Holdings Co., Ltd.,
  • Fresenius SE & Co. KGaA
  • Reckitt Benckiser Group Plc
  • Perrigo Co. Plc
  • Ingredion Inc.
  • Solace Nutrition

Infant Clinical Nutrition Industry Research by Category

By Product Type:

  • Milk-Based
  • Soy-Based
  • Organic
  • Probiotic/Prebiotic

By Route of Administration:

  • Oral administration
  • Enteral administration
  • Intravenous administration

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
    • 3.1.1. Increasing Birth Rate with the Growing Number of Premature Births Creates Needs for Infant Nutrition Supplements
    • 3.1.2. Advancements in the Nutritional Modifications in the Infant Food Products to Boost the Market Growth
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Strategic Promotional Strategies

5. Global Infant Clinical Nutrition Market - Pricing Analysis

  • 5.1. Regional Pricing Trend Analysis, 2019-2023
  • 5.2. Global Average Pricing Analysis Benchmark

6. Global Infant Clinical Nutrition Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Global GDP Growth Outlook
    • 7.1.2. Global Food & Beverage industry Overview
    • 7.1.3. Global GDP and Infrastructure Investment
    • 7.1.4. International Trade
    • 7.1.5. Global Industry Outlook
  • 7.2. Forecast Factors - Relevance & Impact
    • 7.2.1. Top Companies Historical Growth
    • 7.2.2. GDP Growth forecast
    • 7.2.3. Manufacturing Industry forecast
    • 7.2.4. Global Urbanization Growth Outlook
    • 7.2.5. Business Climate
  • 7.3. Global Food and Beverage Industry Overview
  • 7.4. Global Dairy Industry Overview
  • 7.5. Supply Chain & Value-Chain Analysis
    • 7.5.1. Raw Material Suppliers
    • 7.5.2. Product Manufacturers
    • 7.5.3. Distribution Channel Industries
  • 7.6. Policy Developments and Regulatory Scenario
    • 7.6.1. The United States Food and Drug Administration (FDA)
    • 7.6.2. Canadian Food Inspection Agency
    • 7.6.3. European Food Safety Authority (EFSA)
    • 7.6.4. The Food Safety and Standards Authority of India (FSSAI)
    • 7.6.5. Ministry of Health, Labor and Welfare. (MHLW), Japan
    • 7.6.6. National Health Commission (NHC), China
    • 7.6.7. Food Standards Australia New Zealand (FSANZ)
  • 7.7. Market Dynamics
    • 7.7.1. Drivers
    • 7.7.2. Restraints
    • 7.7.3. Opportunity Analysis
  • 7.8. Global Supply Demand Analysis

8. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2033
    • 8.3.1. Milk-Based
    • 8.3.2. Soy-Based
    • 8.3.3. Organic
    • 8.3.4. Probiotic/Prebiotic
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, By Route of Administration

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Route of Administration, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Route of Administration, 2024-2033
    • 9.3.1. Oral administration
    • 9.3.2. Enteral administration
    • 9.3.3. Intravenous administration
  • 9.4. Market Attractiveness Analysis By Route of Administration

10. Global Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia and Pacific
    • 10.3.5. East Asia
    • 10.3.6. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
    • 11.4.2. By Product Type
    • 11.4.3. By Route of Administration
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By Route of Administration
  • 11.6. Market Trends
  • 11.7. Key Market Participants - Intensity Mapping
  • 11.8. Drivers and Restraints - Impact Analysis

12. Latin America Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Argentina
      • 12.4.1.4. Rest of Latin America
    • 12.4.2. By Product Type
    • 12.4.3. By Route of Administration
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By Route of Administration
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Europe Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. Italy
      • 13.4.1.3. France
      • 13.4.1.4. U.K.
      • 13.4.1.5. Spain
      • 13.4.1.6. BENELUX
      • 13.4.1.7. Russia
      • 13.4.1.8. Poland
      • 13.4.1.9. Rest of Europe
    • 13.4.2. By Product Type
    • 13.4.3. By Route of Administration
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By Route of Administration
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. South Asia and Pacific Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. India
      • 14.4.1.2. ASEAN
      • 14.4.1.3. Oceania (Australia & New Zealand)
      • 14.4.1.4. Rest of South Asia & Pacific
    • 14.4.2. By Product Type
    • 14.4.3. By Route of Administration
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By Route of Administration
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
    • 15.4.2. By Product Type
    • 15.4.3. By Route of Administration
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By Route of Administration
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Infant Clinical Nutrition Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. GCC Countries
      • 16.4.1.2. Turkey
      • 16.4.1.3. Northern Africa
      • 16.4.1.4. South Africa
      • 16.4.1.5. Rest of Middle East and Africa
    • 16.4.2. By Product Type
    • 16.4.3. By Route of Administration
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product Type
    • 16.5.3. By Route of Administration
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Country Wise Infant Clinical Nutrition Market Analysis, 2024

  • 17.1. Introduction
    • 17.1.1. Market Value Proportion Analysis, By Key Countries
    • 17.1.2. Global Vs. Country Growth Comparison
  • 17.2. U.S. Infant Clinical Nutrition Market Analysis
    • 17.2.1. By Product Type
    • 17.2.2. By Route of Administration
  • 17.3. Canada Infant Clinical Nutrition Market Analysis
    • 17.3.1. By Product Type
    • 17.3.2. By Route of Administration
  • 17.4. Mexico Infant Clinical Nutrition Market Analysis
    • 17.4.1. By Product Type
    • 17.4.2. By Route of Administration
  • 17.5. Brazil Infant Clinical Nutrition Market Analysis
    • 17.5.1. By Product Type
    • 17.5.2. By Route of Administration
  • 17.6. Argentina Infant Clinical Nutrition Market Analysis
    • 17.6.1. By Product Type
    • 17.6.2. By Route of Administration
  • 17.7. Germany Infant Clinical Nutrition Market Analysis
    • 17.7.1. By Product Type
    • 17.7.2. By Route of Administration
  • 17.8. Italy Infant Clinical Nutrition Market Analysis
    • 17.8.1. By Product Type
    • 17.8.2. By Route of Administration
  • 17.9. France Infant Clinical Nutrition Market Analysis
    • 17.9.1. By Product Type
    • 17.9.2. By Route of Administration
  • 17.10. U.K. Infant Clinical Nutrition Market Analysis
    • 17.10.1. By Product Type
    • 17.10.2. By Route of Administration
  • 17.11. Spain Infant Clinical Nutrition Market Analysis
    • 17.11.1. By Product Type
    • 17.11.2. By Route of Administration
  • 17.12. Poland Infant Clinical Nutrition Market Analysis
    • 17.12.1. By Product Type
    • 17.12.2. By Route of Administration
  • 17.13. Russia Infant Clinical Nutrition Market Analysis
    • 17.13.1. By Product Type
    • 17.13.2. By Route of Administration
  • 17.14. China Infant Clinical Nutrition Market Analysis
    • 17.14.1. By Product Type
    • 17.14.2. By Route of Administration
  • 17.15. Japan Infant Clinical Nutrition Market Analysis
    • 17.15.1. By Product Type
    • 17.15.2. By Route of Administration
  • 17.16. S. Korea Infant Clinical Nutrition Market Analysis
    • 17.16.1. By Product Type
    • 17.16.2. By Route of Administration
  • 17.17. India Infant Clinical Nutrition Market Analysis
    • 17.17.1. By Product Type
    • 17.17.2. By Route of Administration
  • 17.18. Oceania (Australia and New Zealand) Infant Clinical Nutrition Market Analysis
    • 17.18.1. By Product Type
    • 17.18.2. By Route of Administration
  • 17.19. Turkey Infant Clinical Nutrition Market Analysis
    • 17.19.1. By Product Type
    • 17.19.2. By Route of Administration
  • 17.20. South Africa Infant Clinical Nutrition Market Analysis
    • 17.20.1. By Product Type
    • 17.20.2. By Route of Administration

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies (Infant Clinical Nutrition)
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Abbott Laboratories
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.1.4. Sales Footprint
      • 19.3.1.5. Strategy Overview
    • 19.3.2. Baxter International
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.2.4. Sales Footprint
      • 19.3.2.5. Strategy Overview
    • 19.3.3. Nestle S.A.
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.3.4. Sales Footprint
      • 19.3.3.5. Strategy Overview
    • 19.3.4. Danone
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.4.4. Sales Footprint
      • 19.3.4.5. Strategy Overview
    • 19.3.5. Meiji Holdings Co., Ltd.
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.5.4. Sales Footprint
      • 19.3.5.5. Strategy Overview
    • 19.3.6. Fresenius SE & Co. KGaA
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.6.4. Sales Footprint
      • 19.3.6.5. Strategy Overview
    • 19.3.7. Reckitt Benckiser Group Plc
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.7.4. Sales Footprint
      • 19.3.7.5. Strategy Overview
    • 19.3.8. Perrigo Co. Plc
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.8.4. Sales Footprint
      • 19.3.8.5. Strategy Overview
    • 19.3.9. Ingredion Inc.
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.9.4. Sales Footprint
      • 19.3.9.5. Strategy Overview
    • 19.3.10. Solace Nutrition
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.10.4. Sales Footprint
      • 19.3.10.5. Strategy Overview
    • 19.3.11. Others ( on Additional Request)
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 19.3.11.4. Sales Footprint
      • 19.3.11.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology